Navigation Links
Accuray Announces Results for Third Quarter of Fiscal 2011
Date:5/5/2011

isks and uncertainties that may lead to actual results varying materially from the forward looking statements. Accordingly, investors are cautioned not to place undue reliance on such statements. Many factors could cause actual performance or results to differ materially from these forward looking statements, including, but not limited to the uncertainties associated with the medical device industry; variability of installation and sales cycle including customer financing and construction delays; changes in the regulatory environment, including reimbursement for CyberKnife procedures; market acceptance of products; and the impact of competition. These and other risks are discussed under the heading "Risk Factors" in our report on Form 10-K for the 2010 fiscal year which has been filed with the Securities and Exchange Commission, as updated in our Form 10-Q to be filed on or before May 10, 2011. The Company assumes no obligation to update forward-looking statements to reflect actual performance or results, changes in assumptions or changes in other factors affecting forward-looking information. Accuray IncorporatedUnaudited Condensed Consolidated Statements of Operations(in thousands, except per share data)Three Months EndedNine Months EndedMarch 31,March 31,2011201020112010Net revenue:Products

$35,249$33,783$88,915$99,815Shared ownership programs

3354841,8561,421Services

18,25317,54554,83357,887Other

9101281,457714Total net revenue

54,74751,940147,061159,837Cost of revenue:Cost of products

14,11414,43034,50846,638Cost of shared ownership programs

85228379877Cost of services

12,15211,80635,39738,859Cost of other

1,0831001,761503Total cost of revenue

27,43426,56472,04586,877Gross profit

27,31325,37675,01672,960Operating expenses:Selling and marketing

8,1277,17923,87425,891Research and development

9,2917,71926,65123,150General and administrative

10,4217,
'/>"/>

SOURCE Accuray Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Accuray Incorporated Announces HSR Clearance in Acquisition of TomoTherapy
2. Accuray Incorporated to Report Financial Results for Third Quarter of Fiscal 2011
3. Accuray Incorporated to Speak at 10th Annual Needham Healthcare Conference
4. Accuray to Acquire TomoTherapy for Approximately $277 Million in Cash and Stock
5. Accurays General Counsel Wins Best Bay Area Corporate Counsel Award
6. Accuray Announces Results for Second Quarter of Fiscal 2011
7. Accuray Hires Chief Marketing Officer
8. Accuray Elevated to NASDAQ Global Select Market
9. Accuray Incorporateds CEO to Speak at 29th Annual J.P. Morgan Healthcare Conference
10. Accuray Establishes Medical Affairs Function
11. Accuray Receives FDA Clearance for the CyberKnife® Systems Lung Optimized Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... and HAMPTON, N.J. , March 5, ... MNK ), a leading global specialty biopharmaceutical company, ... today that they have entered into a definitive agreement ... Inc. from a Madison Dearborn -led investor group ... Subject to customary closing conditions, the parties ...
(Date:3/5/2015)... 05, 2015 Research and Markets ( ... "Global Rising Stars Outlook 2015" report to their ... are being sought after with fresh vigor as new ... which is poised to bring a paradigm change in ... is the Stem cell therapy/Regenerative Medicine space. ...
(Date:3/5/2015)... -- According to a new market research ... Disposables), by Type (Invasive, Minimally Invasive, Non-Invasive), by End-User ... - Analysis & Global Forecast to 2019" , the ... $1,107.4 Million by 2019 from $887.8 Million in 2014, ... 4.5% during the forecast period. Browse ...
Breaking Medicine Technology:Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 2Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 3Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 4Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 5Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 6Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 7Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 8Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 9Global Pharma Rising Stars Outlook 2015 2Hemodynamic Monitoring Systems Market Worth $1,107.4 Million by 2019 2Hemodynamic Monitoring Systems Market Worth $1,107.4 Million by 2019 3Hemodynamic Monitoring Systems Market Worth $1,107.4 Million by 2019 4
... ... ... ... are keyed by longUrl, so we need to grab the first one. for (var r in data.results) { first_result ...
... STEWARTVILLE, Minn., Oct. 25 Rochester Medical Corporation (Nasdaq: ... close on Thursday, November 4, 2010.  The Company will then ...  The call will begin at 3:30 p.m. central time (4:30 ... by Thomson/CCBN and can be accessed at Rochester Medical,s website ...
Cached Medicine Technology:Sanofi-aventis Initiates Phase III Study with Teriflunomide as Adjunct Therapy with Interferon Beta to Further Explore Clinical Benefits in Multiple Sclerosis 2Sanofi-aventis Initiates Phase III Study with Teriflunomide as Adjunct Therapy with Interferon Beta to Further Explore Clinical Benefits in Multiple Sclerosis 3Sanofi-aventis Initiates Phase III Study with Teriflunomide as Adjunct Therapy with Interferon Beta to Further Explore Clinical Benefits in Multiple Sclerosis 4Sanofi-aventis Initiates Phase III Study with Teriflunomide as Adjunct Therapy with Interferon Beta to Further Explore Clinical Benefits in Multiple Sclerosis 5Sanofi-aventis Initiates Phase III Study with Teriflunomide as Adjunct Therapy with Interferon Beta to Further Explore Clinical Benefits in Multiple Sclerosis 6Sanofi-aventis Initiates Phase III Study with Teriflunomide as Adjunct Therapy with Interferon Beta to Further Explore Clinical Benefits in Multiple Sclerosis 7Sanofi-aventis Initiates Phase III Study with Teriflunomide as Adjunct Therapy with Interferon Beta to Further Explore Clinical Benefits in Multiple Sclerosis 8Sanofi-aventis Initiates Phase III Study with Teriflunomide as Adjunct Therapy with Interferon Beta to Further Explore Clinical Benefits in Multiple Sclerosis 9Sanofi-aventis Initiates Phase III Study with Teriflunomide as Adjunct Therapy with Interferon Beta to Further Explore Clinical Benefits in Multiple Sclerosis 10Sanofi-aventis Initiates Phase III Study with Teriflunomide as Adjunct Therapy with Interferon Beta to Further Explore Clinical Benefits in Multiple Sclerosis 11Rochester Medical Announces Fourth Quarter 2010 Earnings Conference Call Thursday, November 4, 2010 2
(Date:3/5/2015)... A Bakersfield, Calif. state court jury returned a verdict this ... Coleen M. Perry a total of $5.7 million for damages ... sling device, manufactured by Ethicon, Inc., a subsidiary of Johnson ... Wagstaff & Cartmell in Kansas City, Mo., was ... Freese and Tim Goss of Freese & Goss ...
(Date:3/5/2015)... York (PRWEB) March 05, 2015 Testosterone ... who allegedly suffered heart attacks, strokes and other serious ... testosterone therapies continue to move forward in the federal ... District of Illinois. According to a Case Management Order ... procedures for the use of master pleadings in the ...
(Date:3/5/2015)... 2015 HomeCEUConnection.com is proud ... extra savings on their nutrition CEUs. To ... and nutrition, HomeCEUConnection.com is offering 10% off ... code, NUTRITION2015 . , High Quality ... HomeCEUConnection.com provides high-quality continuing education courses for ...
(Date:3/5/2015)... 05, 2015 SuperCloset has released a new ... series aims to teach viewers everything they need to know ... Like a SuperPro takes you from seed all the way ... clone, to how to prune Grow Like a SuperPro will ... the whole series for download for a special introductory price ...
(Date:3/5/2015)... At the 7th Annual Mississippi Addiction ... treatment met today in Jackson, Mississippi to listen to ... the numerous respected speakers will be William S. ... that pain medications have had in today’s opiate overdose ... "It is hard to believe that much of the ...
Breaking Medicine News(10 mins):Health News:Client Wins $5.7 Million in TVT-Abbrevo Verdict against Johnson & Johnson in California State Court 2Health News:Testosterone Lawsuits Move Forward, as Bernstein Liebhard LLP Comments on Most Recent Order Issued in Federal Litigation 2Health News:Testosterone Lawsuits Move Forward, as Bernstein Liebhard LLP Comments on Most Recent Order Issued in Federal Litigation 3Health News:Testosterone Lawsuits Move Forward, as Bernstein Liebhard LLP Comments on Most Recent Order Issued in Federal Litigation 4Health News:HomeCEUConnection.com Offers Nutrition CEUs this March to Celebrate Nutrition Month 2Health News:National Addiction Treatment Expert William S. “Bill” Jacobs, Md Speaks At Prestigious 7th Annual Mississippi Addiction Conference 2Health News:National Addiction Treatment Expert William S. “Bill” Jacobs, Md Speaks At Prestigious 7th Annual Mississippi Addiction Conference 3
... zero in (on) the modalities of a drug, capable of ... trials on animal models have revealed the capacity of the ... charge of energy production., ,'Many drugs block the ... who is the Werner E. Bachmann Collegiate Professor of Chemistry ...
... renowned medical specialist, NHS can be freed from its’ ... reconsidered before they are implemented. // It is amply ... may make matters worse for the deprived and under ... has led to low morale among Doctors and NHS ...
... has announced the launch of BARACLUDE? (entecavir) for ... its approval by the Drug Controller General of India. ... of chronic hepatitis B virus infection in adults with ... persistent elevations in serum aminotransferases (ALT or AST) or ...
... warned that hospitals are repeatedly failing to implement rules ... to patients //from contaminated surgical instruments. ,The ... in sets so they can be traced easily. Instead ... ,Dr Gill Morgan, chief executive of the NHS ...
... with medical services functioning smoothly and the institute's director ... and attending to patients - a day after the ... ,While health services normalised in AIIMS after doctors, ... their agitation last evening following the court order, the ...
... diseases that has affected everyone from Henry VIII to Christoper ... near the site of infection//. The primary sore first appears ... clear. , This is followed by generalized skin rash, ... few months or years later tertiary syphilis develops which destroys ...
Cached Medicine News:Health News:Autoimmune disorders studied in detail by U-M researchers. 2Health News:India Approves Baraclude? (entecavir) For ,Treatment Of Chronic HEPATITIS B 2
... The Bledsoe Revolution Knee ... speed fitting under post-op ... the surgeon or authorized ... post-op fitting and application ...
The Bledsoe Post-Op Knee Brace is designed to provide maximum protection without sacrificing comfort and quick, easy application....
... Room Knee Brace frees the ... the time-consuming post-op fitting and ... more complex brace designs. The ... provides the same benefits as ...
... Cronin, Inc. is a ... Footwear, Orthopedic Softgoods, and ... Our products are of ... available in the USA ...
Medicine Products: